| Stage | ICHR | % of rev | NVDA | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $295M | 100.00% | $96.2B | 100.00% | NVDA ×326.41 |
| Gross profit | $41M | 13.90% | $72.1B | 74.98% | NVDA +61.1pp |
| Operating income | $7M | 2.44% | $63.7B | 66.24% | NVDA +63.8pp |
| Pre-tax income | $5M | 1.84% | $71.5B | 74.32% | NVDA +72.5pp |
| Net income | $998,000 | 0.34% | $59.7B | 62.03% | NVDA +61.7pp |
| Stage | ICHR | NVDA | Gap · A − B |
|---|---|---|---|
| Revenue | $295M100.00% | $96.2B100.00% | NVDA ×326.41 |
| Gross profit | 13.90%$41M | 74.98%$72.1B | NVDA +61.1pp |
| Operating income | 2.44%$7M | 66.24%$63.7B | NVDA +63.8pp |
| Pre-tax income | 1.84%$5M | 74.32%$71.5B | NVDA +72.5pp |
| Net income |
| 0.34%$998,000 |
| 62.03%$59.7B |
| NVDA +61.7pp |